doi: 10.1089/hum.2020.252.
Epub 2020 Oct 30.
Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World
Affiliations
- PMID: 32998595
- PMCID: PMC10112459
- DOI: 10.1089/hum.2020.252
Item in Clipboard
Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World
Hum Gene Ther.
2021 Jan.
No abstract available
Conflict of interest statement
No competing financial interests exist.
Figures
The vision for the HIV Frontiers Program.
The key elements of the HIV Frontiers Program.
Critical considerations in the discovery, development, and clinical application of therapies targeting and editing long-lived cells in vivo.
Similar articles
-
Affordable HIV and sickle cell disease gene therapies.Nat Rev Drug Discov. 2019 Nov;18(12):895. doi: 10.1038/d41573-019-00189-3. Nat Rev Drug Discov. 2019. PMID: 31780850 No abstract available.
-
Genetic therapies for HIV infections: promise for the future.AIDS. 1995 Sep;9(9):985-93. doi: 10.1097/00002030-199509000-00002. AIDS. 1995. PMID: 8527094 Review. No abstract available.
-
[This is how the "gene scissors" function against HIV].MMW Fortschr Med. 2016 Jun 9;158 Suppl 1:10. doi: 10.1007/s15006-016-8315-9. MMW Fortschr Med. 2016. PMID: 27259889 German. No abstract available.
-
Gene therapy for HIV-1 infection.Adv Exp Med Biol. 1996;394:421-8. doi: 10.1007/978-1-4757-9209-6_39. Adv Exp Med Biol. 1996. PMID: 8815708 Review. No abstract available.
-
Prospects for the therapeutic application of lentivirus-based gene therapy to HIV-1 infection.Curr Gene Ther. 2008 Feb;8(1):1-8. doi: 10.2174/156652308783688536. Curr Gene Ther. 2008. PMID: 18336245 Review.
Cited by
-
Collaborative science to advance gene therapies in resource-limited parts of the world.Mol Ther. 2021 Nov 3;29(11):3101-3102. doi: 10.1016/j.ymthe.2021.05.024. Epub 2021 Aug 30. Mol Ther. 2021. PMID: 34464598 Free PMC article. No abstract available.
-
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.BMC Med Ethics. 2022 Apr 9;23(1):39. doi: 10.1186/s12910-022-00780-1. BMC Med Ethics. 2022. PMID: 35397551 Free PMC article.
-
The promise of a "cure" for HIV: implications for the future of PEPFAR-supported HIV programmes.J Int AIDS Soc. 2024 Jan;27(1):e26206. doi: 10.1002/jia2.26206. J Int AIDS Soc. 2024. PMID: 38193636 Free PMC article. No abstract available.
-
The long-term impact and value of curative therapy for HIV: a modelling analysis.J Int AIDS Soc. 2023 Sep;26(9):e26170. doi: 10.1002/jia2.26170. J Int AIDS Soc. 2023. PMID: 37749063 Free PMC article.
-
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Pathog Immun. 2024 Mar 1;8(2):115-157. doi: 10.20411/pai.v8i2.665. eCollection 2023. Pathog Immun. 2024. PMID: 38455668 Free PMC article.
References
-
- United Nations Joint Programme on HIV/AIDS (UNAIDS). 2018. The youth bulge and HIV. https://www.unaids.org/sites/default/files/media_asset/the-youth-bulge-a.... (last accessed September 22, 2020).
-
- Hutter G, Nowak D, Mossner M, et al. . Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009;360:692–698. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
